Glucose Intolerance: all 792 studies

Page 8 of 8. Open to participants first (126), then studies with results posted, then the rest; newest registration first within each.

• Investigation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LIM-0705 in Male Subjects With Impaired Glucose ToleranceWithdrawnNCT01093677Phase 1
• Biomarkers of Metabolic Syndrome and PrediabetesCompletedNCT01086137
• Effect of a Single Colecalciferol Dose on Insulin ResistanceStatus unknownNCT01075022Not applicable
• Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin ResistanceStatus unknownNCT01052025Phase 4
• Progression to Impaired Glucose Tolerance and Type 2 Diabetes in the Korean People-based KNDP StudyCompletedNCT01034826
• Prevention of Type 2 Diabetes in Children With a Family-based Healthy Lifestyle ProgramCompletedNCT01030978Not applicable
• Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational DiabetesCompletedNCT01022645
• Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)CompletedNCT01020955Phase 3
• Low Density Lipoprotein (LDL) Cholesterol Metabolism in Impaired Glucose ToleranceCompletedNCT01020578
• Vitamin D to Improve Glucose Metabolism and Reduce Inflammation in Obese AdolescentsCompletedNCT00994396Not applicable
• The Effect of Nordic Recommended Diet on the Features of Metabolic Syndrome - Multicentre StudyCompletedNCT00992641Not applicable
• Diabetes Prevention In EstrieCompletedNCT00991549Not applicable
• Effects of Exenatide on Postprandial Hyperlipidemia and InflammationCompletedNCT00974272Phase 4
• Biomarkers of Prednisolone Treatment (P05888)CompletedNCT00971724Not applicable
• Age, Lifestyle, Muscle Mechanisms in Insulin ResistanceCompletedNCT00971594Not applicable
• Identification of Predictors of Success for Lifestyle Modifications in Overweight Pre-diabetic SubjectsCompletedNCT00969007Not applicable
• Effect of Sitagliptin in Impaired Glucose ToleranceStatus unknownNCT00961363Phase 2
• Cassia Cinnamon for Glucose Uptake in Young WomenCompletedNCT00951639Not applicable
• Evaluating the Effects of a Diet and Exercise Program in People With Type 2 Diabetes or Prediabetes: (The SHAPE3 Study)CompletedNCT00928005Phase 4
• Type 2 Diabetes and Acute Myocardial InfarctionStatus unknownNCT00926133
• Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic SyndromeCompletedNCT00917449Phase 3
• Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)CompletedNCT00862589Not applicable
• Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)Status unknownNCT00858676Phase 4
• Integrating Lifestyle Therapy for Diabetes Prevention Into Primary CareCompletedNCT00853801Not applicable
• Exercise Effects on Cardiovascular Risk Factors, Quality of Life, Muscle Function in Type 2 Diabetes and Healthy PersonsStatus unknownNCT00852982Not applicable
• Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose ToleranceCompletedNCT00847899Phase 2
• The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young AdultsWithdrawnNCT00845559Phase 4
• The Role of Pulsatile Insulin Secretion (A Study Investigating the Effects of Partial Pacreatectomy on Glucose Metabolism)CompletedNCT00841867
• Acarbose Cardiovascular Evaluation TrialCompletedNCT00829660Phase 4
• The Effect of Maximum Body Weight in Lifetime on the Development of Type 2 DiabetesCompletedNCT00816608
• A Survey on the Rate of Glucose Intolerance in Hong Kong ChineseStatus unknownNCT00787215
• A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong KongStatus unknownNCT00786890
• Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin EffectCompletedNCT00784745Not applicable
• Sitagliptin in Renal Transplant RecipientsCompletedNCT00740363Phase 4
• Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose ToleranceStatus unknownNCT00733174Phase 4
• Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.Status unknownNCT00724542Not applicable
• Anti-Inflammatory Effects of PioglitazoneCompletedNCT00722631Not applicable
• Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical DecayStatus unknownNCT00687466Phase 3
• Vitamin D for the Prevention of Diabetes Type 2CompletedNCT00685594Phase 2/3
• Physical Exercise Versus Rosiglitazone in CAD and PrediabetesCompletedNCT00675740Phase 4
• Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin ResistanceCompletedNCT00663000
• Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic PatientsCompletedNCT00652379Not applicable
• Healthy Living Partnership to Prevent DiabetesCompletedNCT00631345Not applicable
• Beta-cell Function in Glucose Abnormalities and Acute Myocardial InfarctionCompletedNCT00627744Phase 4
• Treatment of Impaired Glucose Tolerance in PregnancyCompletedNCT00625781Not applicable
• Gender Differences in Prevalence of Undiagnosed Diabetes in ACSCompletedNCT00589459
• C-reactive Protein and Endothelial Dysfunction in Women With Glucose IntoleranceCompletedNCT00589355
• Dietary Modulation of Gene Expression and Metabolic Pathways in Glucose MetabolismCompletedNCT00573781Phase 2
• Effect of Increased Intake of Low Fat Dairy Products on Weight Loss and Insulin ResistanceCompletedNCT00564551Not applicable
• Study of Vanadium Supplement in Patients With Impaired Glucose ToleranceCompletedNCT00561132Phase 3
• Regulation of B-Cell Function & Glucose Tolerance in Older PeopleTerminatedNCT00554112Not applicable
• Study to Investigate the Pathophysiology of Type 2 Diabetes in YouthCompletedNCT00536250
• Chronic Inflammatory Activation in Fat Tissue: An Atherogenic Factor in Severe Coronary Artery DiseaseTerminatedNCT00510705Not applicable
• Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery DiseaseCompletedNCT00510588Not applicable
• To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT PatientsCompletedNCT00489229Phase 3
• Effects of Colesevelam HCl On Bile Acid KineticsCompletedNCT00476710
• The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance PatientsStatus unknownNCT00472342Not applicable
• Paleolithic Diet in the Treatment of Glucose IntoleranceCompletedNCT00419497Phase 2/3
• Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 DiabetesStatus unknownNCT00417950Not applicable
• Exercise Training, Insulin Resistance and Coronary Artery DiseaseCompletedNCT00412815Phase 3
• Telmisartan and Losartan in Hypertensive IGTCompletedNCT00407862Phase 4
• Automated Diabetes Prevention ProgramCompletedNCT00384488Not applicable
• Impact of 3-year Lifestyle Intervention on Postprandial Glucose Metabolism: the SLIM StudyCompletedNCT00381186Not applicable
• 11ß-HSD1 and Metabolic SyndromeCompletedNCT00370305Phase 2
• Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic AdultsCompletedNCT00352287Phase 4
• Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese SubjectsTerminatedNCT00319202Phase 4
• Efficacy and Safety of Nateglinide Treatment in Renal Transplant RecipientsCompletedNCT00319189Phase 4
• A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetesCompletedNCT00312130Phase 3
• Pioglitazone in Impaired Glucose ToleranceWithdrawnNCT00306826Phase 4
• Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT)CompletedNCT00301392Phase 4
• The Metabolic Effects of Almond Consumption in Adults With Pre-DiabetesCompletedNCT00270985Phase 1
• Diagnosis of Insulin Resistance: 13C-Glucose Breath Test Vs HOMA Index.Status unknownNCT00264940
• Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose ToleranceCompletedNCT00241072Phase 4
• Prevention of Corticosteroid-induced Glucose IntoleranceStatus unknownNCT00240604Phase 3
• Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose ToleranceCompletedNCT00237250Phase 3
• The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal PolyneuropathyTerminatedNCT00228345Phase 1
• Cognitive Effects of Aerobic Exercise for IGT AdultsCompletedNCT00220441Phase 2
• Effective Endurance Training in Metabolic SyndromeCompletedNCT00218998Not applicable
• Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGTTerminatedNCT00212017Not applicable
• The Study of Atherosclerosis With Ramipril and RosiglitazoneCompletedNCT00140647Phase 3
• Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose IntoleranceCompletedNCT00129233Phase 4
• A Lifestyle and Combination Medication Therapy Diabetes Prevention StudyCompletedNCT00116922Phase 3
• Effects of Insulin Sensitizers in Subjects With Impaired Glucose ToleranceCompletedNCT00108615Phase 4
• The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) TrialCompletedNCT00095654Phase 3
• Chromium Effects on Insulin and Vascular Function in People at Risk for DiabetesCompletedNCT00067626Phase 2
• Metabolic Abnormalities in HIV Infected and Uninfected Young WomenCompletedNCT00067587
• Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II DiabetesCompletedNCT00064727Phase 2
• Type 2 Diabetes Primary Prevention for At Risk GirlsCompletedNCT00063674Not applicable
• Lifestyle Interventions to Reduce Diabetes RiskCompletedNCT00006162Not applicable
• Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and/or Type 2 DiabetesCompletedNCT00005760
• Diabetes Prevention ProgramCompletedNCT00004992Phase 3
• Prevalence of Carbohydrate Intolerance in Lean and Obese ChildrenStatus unknownNCT00000112

← Glucose Intolerance overview